Updates are available Correction dated 2024-06-18
Click to view Correction: https://doi.org/10.1038/s41586-024-07659-8
-
Authors
Riva, Laura
Yuan, Shuofeng
Yin, Xin https://orcid.org/0000-0003-2357-6718
Martin-Sancho, Laura
Matsunaga, Naoko
Pache, Lars https://orcid.org/0000-0002-4193-1042
Burgstaller-Muehlbacher, Sebastian https://orcid.org/0000-0003-4640-3510
De Jesus, Paul D.
Teriete, Peter
Hull, Mitchell V.
Chang, Max W.
Chan, Jasper Fuk-Woo
Cao, Jianli
Poon, Vincent Kwok-Man
Herbert, Kristina M.
Cheng, Kuoyuan
Nguyen, Tu-Trinh H.
Rubanov, Andrey
Pu, Yuan
Nguyen, Courtney
Choi, Angela
Rathnasinghe, Raveen
Schotsaert, Michael https://orcid.org/0000-0003-3156-3132
Miorin, Lisa
Dejosez, Marion
Zwaka, Thomas P.
Sit, Ko-Yung
Martinez-Sobrido, Luis https://orcid.org/0000-0001-7084-0804
Liu, Wen-Chun
White, Kris M. https://orcid.org/0000-0003-0889-0506
Chapman, Mackenzie E.
Lendy, Emma K.
Glynne, Richard J.
Albrecht, Randy https://orcid.org/0000-0003-4008-503X
Ruppin, Eytan
Mesecar, Andrew D. https://orcid.org/0000-0002-1241-2577
Johnson, Jeffrey R.
Benner, Christopher
Sun, Ren https://orcid.org/0000-0002-8628-7019
Schultz, Peter G.
Su, Andrew I. https://orcid.org/0000-0002-9859-4104
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Chatterjee, Arnab K. https://orcid.org/0000-0001-5171-7982
Yuen, Kwok-Yung https://orcid.org/0000-0002-2083-1552
Chanda, Sumit K. https://orcid.org/0000-0001-9399-7927
- License Information
-
More Information
Article History
Received: 20 April 2020
Accepted: 17 July 2020
First Online: 24 July 2020
Change Date: 18 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-07659-8
Competing interests
: J.F.-W.C. has received travel grants from Pfizer Corporation Hong Kong and Astellas Pharma Hong Kong Corporation Limited and was an invited speaker for Gilead Sciences Hong Kong Limited and Luminex Corporation. A.G.-S. is inventor on patent applications on antiviral compounds against SARS-CoV-2 unrelated to this study and owned by the Icahn School of Medicine at Mount Sinai. A.K.C. and S.K.C. are inventors on a patent application on repurposed antiviral compounds for SARS-CoV-2 owned by Scripps Research and Sanford Burnham Prebys. US Patent Application Serial No. 63/010630, entitled <i>Methods and Compositions for Antiviral Treatment</i> relates to aspects of this work and was filed on 15 April 2020. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. The other authors declare no competing interests.
Free to read: This content has been made available to all.
